⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AGIO News
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - AGIO
accessnewswire.com
AGIO
Lost Money on Agios Pharmaceuticals, Inc. (AGIO)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
accessnewswire.com
AGIO
Agios Pharmaceuticals, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - AGIO
accessnewswire.com
AGIO
Agios Pharmaceuticals, Inc. Being Investigated on Behalf of Agios Pharmaceuticals, Inc. Investors. Contact Levi & Korsinsky For Details
accessnewswire.com
AGIO
Shareholder Rights Advocates at Levi & Korsinsky Investigate Agios Pharmaceuticals, Inc. (AGIO) Regarding Possible Securities Fraud Violations
accessnewswire.com
AGIO
Investors in Agios Pharmaceuticals, Inc. (AGIO) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today
accessnewswire.com
AGIO
Agios Announces Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease
globenewswire.com
AGIO
Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition
globenewswire.com
AGIO
Agios Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
AGIO
Avanzanite Bioscience’s Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia
businesswire.com
AGIO